HighTide Therapeutics Email Formats

Pharmaceutical Manufacturing • 9th to 10th Floor, Building D, Hong Kong • 11-20 Employees

HighTide Therapeutics Email Formats

HighTide Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@hightidetx.com), used 63.6% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@hightidetx.com	63.6%
{first name}{last name}	johndoe@hightidetx.com	36.4%

Key Contacts at HighTide Therapeutics

Liping Liu

Founder, Ceo & Cso

Wan-Jen Yang

Director Of Biology

Alex Liberman

Director, Clinical Science

Kjersti Swearingen

Associate Director, Medical Writing

Company overview

Headquarters	9th to 10th Floor, Building D, Shenfang Park, Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone, Fubao Street, Futian District, Shenzhen, Guangdong, CN
Website	hightidetx.com
NAICS	3254
SIC	873
Founded	2011
Employees	11-20
Socials

About HighTide Therapeutics

HighTide Therapeutics, Inc. (2511.HK) is a globally integrated biopharmaceutical company focusing on the discovery and development of first-in-class multifunctional multi-targeted therapies with chronic liver and metabolic diseases with significant unmet medical needs. The company is developing multiple clinical assets, including therapy for metabolic dysfunction-associated steatohepatitis (MASH), type 2 diabetes (T2DM), severe hypertriglyceridemia (SHTG), primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC). Berberine ursodeoxycholate (HTD1801), the company’s lead drug candidate, received Fast Track designation from the U.S. FDA for both MASH and PSC, as well as Orphan Drug designation for PSC. In China, HTD1801 has been included in the National Major New Drug Innovation Program under the 13th Five-Year Plan for Major Technology Project.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

C-Suite

Head

Employees by Department

HighTide Therapeutics has 4 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore HighTide Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-02-04	6	$107,000,000
2023-02-05	6	$107,000,000

Funding Insights

$214,000,000

Total funding amount

$107,000,000

Most recent funding amount

Number of funding rounds

HighTide Therapeutics Tech Stack

Discover the technologies and tools that power HighTide Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Baidu Analytics

Analytics

jQuery

JavaScript libraries

GoDaddy

Hosting

Nginx

Reverse proxies

HSTS

Security

GSAP

JavaScript frameworks

Swiper

JavaScript libraries

Animate.css

UI frameworks

Google Font API

Font scripts

Frequently asked questions

HighTide Therapeutics is located in 9th to 10th Floor, Building D, HK.

HighTide Therapeutics was founded in 2011, making it 15 years old. The company has established itself as a significant player in its industry over this time.

HighTide Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

HighTide Therapeutics has raised a total of $214,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.